Effect of parenteral L-carnitine in hospitalized patients with moderate to severe COVID-19: A randomized double-blind clinical trial

Effect of parenteral L-carnitine in hospitalized patients with moderate to severe COVID-19: A randomized double-blind clinical trial

Introduction: Pro-inflammatory responses have an important role in developing coronavirus disease 2019 (COVID-19). L-carnitine (LC) has been known to possess anti-inflammatory, anticoagulant, and antiviral effects. So, we aimed to evaluate the efficacy of LC in hospitalized patients with moderate-to...

Full description

Saved in:
Bibliographic Details
Main Authors: Farnaz Naeimzadeh, Armin Sadeghi, Seiedhadi Saghaleini, Parvin Sarbakhsh, Ata Mahmoodpoor, Afshin Gharekhani
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-04-01
Series:BioImpacts
Subjects:
l-carnitine
levocarnitine
covid-19
sars-cov-2
c-reactive protein
ferritin
d-dimer ‎
lactate dehydrogenase
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-15-30261.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bi.tbzmed.ac.ir/PDF/bi-15-30261.pdf

Similar Items